Vaccination in the Era of Immunosuppression
Fatima Alnaimat(University of Jordan), Nadera Sweiss(University of Illinois Chicago), Supritha Prasad(University of Illinois Chicago), Hali A. Hanson(University of Illinois Chicago), Christen Vagts(University of Illinois Chicago), Zeel Modi(University of Illinois Chicago), Jaleel Jerry G. Sweis(University of Illinois Chicago), Ιlias Papanikolaou(Corfu General Clinic), Ayman AbuHelal(Jordan Hospital), Richard M. Novak(Northwestern University), Jacqueline Jansz(University of Illinois Chicago), Israel Rubinstein(Illinois College), Christian Ascoli(University of Illinois Chicago)
Cited by 21
Related Papers
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
|PubMed|2014|505
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Cumulative Incidence of Cancer Among Persons With HIV in North America
|Annals of Internal Medicine|2015|330
Racial Difference in Sarcoidosis Mortality in the United States
|CHEST Journal|2014|251
Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade B<i>gag/pol/nef</i>Vaccine in Healthy Adults
|Clinical Infectious Diseases|2008|246